News | January 07, 2015

Minneapolis Heart Institute Among First in U.S. to Implant Lotus Heart Valve

The Lotus consists of a pre-loaded, stent-mounted tissue valve prosthesis and catheter delivery system for guidance and percutaneous placement of the valve

January 7, 2015 — Minneapolis Heart Institute Foundation (MHIF) researchers have performed two implants of the Lotus Cardiac Valve System as part of the REPRISE III clinical trial. With these procedures, Minneapolis Heart Institute at Abbott Northwestern Hospital has become the third facility in the United States to perform Lotus valve implants, and the first west of the Mississippi.

The patients, who were the seventh and eighth to receive Lotus valve implants in the United States, are both 85-year-old women who suffered from advanced aortic valve stenosis and were deemed high-risk and ineligible for traditional valve replacements through open heart surgery.

Both patients underwent transcatheter aortic valve replacement (TAVR) procedures on Tuesday, November 11. They are both scheduled to return to Minneapolis Heart Institute at Abbott Northwestern to assess their progress and to determine whether their TAVR procedures were successful.

Clinical research into TAVR devices such as the Lotus Cardiac Valve System is important because it provides options to an underserved population – older patients that are generally considered too high-risk for open-heart surgery.

Wesley R. Pedersen, M.D., director of Transcatheter Valve Therapies for the Minneapolis Heart Institute at Abbott Northwestern Hospital is the principal investigator for this study. He states, “The ability of this valve to be fully repositioned offers an advantage over existing technology. If initial placement results in suboptimal function, it can be recaptured and moved to a slightly different position where valve function is most ideal.” In the United States the Lotus Valve System is an investigational device and not available for sale. It is CE marked in the European Union.

For more information: www.mplsheart.org

 

Related Content

First TriCinch Coil Tricuspid Repair Systems Implanted in U.S.
News | Heart Valve Technology | November 06, 2018
4Tech Inc. initiated its U.S. Early Feasibility Study of the TriCinich Coil System following U.S. Food and Drug...
Valve Replacement Volume Key to Successful Patient Outcomes
News | Heart Valve Technology | November 02, 2018
Hospitals that routinely perform a heart valve replacement procedure requiring open heart surgery are more likely to...
Prosthetic Valve Mismatches Common in TAVR Procedures
News | Heart Valve Technology | October 03, 2018
A high number of patients in a study who underwent transcatheter aortic valve replacement (TAVR) experienced severe and...
Local Anesthesia Safe and Effective for Intermediate- and High-Risk TAVR Patients
News | Heart Valve Technology | September 28, 2018
The first randomized study to compare general versus local anesthesia during transcatheter aortic valve replacement (...
MitraClip Reduces Mortality for Heart Failure Patients With Secondary Mitral Regurgitation
News | Heart Valve Technology | September 26, 2018
Patients with heart failure and secondary mitral regurgitation (MR) who remained symptomatic despite maximally...
Ancora Heart Announces Positive Interim Analysis of AccuCinch Ventricular Repair System for Heart Failure
News | Heart Valve Technology | September 24, 2018
Ancora Heart Inc. announced positive clinical data from the company’s recently expanded U.S. early feasibility study...
Medtronic Announces TAVR Study of Aortic Stenosis Patients With Bicuspid Valves
News | Heart Valve Technology | September 19, 2018
The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) to initiate a new...
4C Medical's AltaValve First-in-Human Experience to be Presented at TCT 2018
News | Heart Valve Technology | September 17, 2018
September 17, 2018 — 4C Medical Technologies Inc.
Gore Acquires Pipeline Medical Technologies Inc.
News | Heart Valve Technology | September 06, 2018
W. L. Gore & Associates Inc. (Gore) announced the acquisition of Pipeline Medical Technologies Inc., a privately...
Overlay Init